Literature DB >> 1728389

Home chemotherapy for children with cancer.

S Jayabose1, V Escobedo, O Tugal, A Nahaczewski, P Donohue, V Fuentes, G Devereau, S Sunkara.   

Abstract

A program was established in which the parents of children with cancer were trained to administer intravenous chemotherapy to the children in their homes. The main objectives of this program (Home Intravenous Chemotherapy by Parents [HICP]) were to improve the quality of life for children with cancer and their parents and to decrease the cost of medical care for these children by decreasing the number of clinic visits and hospital stays intended solely for the administration of chemotherapy. Twenty-four months of experience with this program indicates that with a close communication network and a good working relationship among a home care organization (HCO), the parents of the patient, a pediatric oncology nurse, and an attending pediatric oncologist, many chemotherapeutic agents can be safely administered to these children by their parents in their homes. The patients and their parents are enthusiastic about this program because of the valuable time saved and the increased participation in care. In addition, this program greatly decreased the cost of medical care for these children.

Entities:  

Mesh:

Year:  1992        PMID: 1728389     DOI: 10.1002/1097-0142(19920115)69:2<574::aid-cncr2820690249>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  Economics of home intravenous services.

Authors:  N D Thickson
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

2.  The Hospital at Home program: no place like home.

Authors:  M Lippert; S Semmens; L Tacey; T Rent; K Defoe; M Bucsis; T Shykula; J Crysdale; V Lewis; D Strother; L Lafay-Cousin
Journal:  Curr Oncol       Date:  2017-02-27       Impact factor: 3.677

3.  Home care--a safe and attractive alternative to inpatient administration of intensive chemotherapies.

Authors:  François Lüthi; Nadia Fucina; Nathalie Divorne; Brigitte Santos-Eggimann; Christine Currat-Zweifel; Patricia Rollier; Jean-Blaise Wasserfallen; Nicolas Ketterer; Serge Leyvraz
Journal:  Support Care Cancer       Date:  2011-03-08       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.